Crinetics Pharma (CRNX)
NASDAQ:CRNX
Crinetics Pharmaceuticals (CRNX) Ownership Overview
1.93% Insiders
38.40% Mutual Funds
0.04% Other Institutional Investors
14.92% ETFs
44.71% Public Companies and Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 53.35% of the company’s stock is owned by Institutional Investors, 1.93% is owned by Insiders, and 44.71% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $76754852 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $35315576 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $297349297 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $322735712 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,852,213 | Institution | 8.45% | 351,875,467 | |
| 7,365,863 | Institution | 7.03% | 292,793,054 | |
| 6,933,098 | Institution | 6.62% | 275,590,646 | |
| 6,387,740 | Institution | 6.10% | 253,912,665 | |
| 5,249,198 | Institution | 5.01% | 208,655,621 | |
| 4,679,108 | Institution | 4.47% | 185,994,543 | |
| 3,494,255 | Institution | 3.34% | 138,896,636 | |
| 2,342,311 | Institution | 2.24% | 93,106,862 | |
| 1,648,869 | Institution | 1.57% | 65,542,543 | |
| 1,492,204 | Institution | 1.43% | 59,315,109 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,365,863 | Institution | 7.03% | 292,793,054 | |
| 5,249,198 | Institution | 5.01% | 208,655,621 | |
| 3,494,255 | Institution | 3.34% | 138,896,636 | |
| 2,342,311 | Institution | 2.24% | 93,106,862 | |
| 1,492,204 | Institution | 1.43% | 59,315,109 | |
| 1,487,736 | Institution | 1.42% | 59,137,506 | |
| 1,234,470 | Institution | 1.18% | 49,070,183 | |
| 1,171,967 | Institution | 1.12% | 46,585,688 | |
| 1,137,972 | Institution | 1.09% | 45,234,387 | |
| 1,119,672 | Institution | 1.07% | 44,506,962 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,237,186 | Institution | 3.09% | 133,048,345 | |
| 2,328,902 | Institution | 2.22% | 95,717,872 | |
| 2,311,191 | Institution | 2.21% | 91,869,842 | |
| 1,293,099 | Institution | 1.23% | 53,146,369 | |
| 1,118,562 | Institution | 1.07% | 45,972,898 | |
| 788,918 | Institution | 0.75% | 31,359,491 | |
| 729,448 | Institution | 0.70% | 28,995,558 | |
| 497,359 | Institution | 0.48% | 19,227,899 | |
| 484,441 | Institution | 0.46% | 19,910,525 | |
| 271,893 | Institution | 0.26% | 10,807,747 |
FAQ
Who Owns Crinetics Pharma (CRNX)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 1.93% is held by insiders, and 44.71% is held by retail investors.
What percentage of Crinetics Pharma (CRNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Crinetics Pharma (CRNX) stock is held by institutional investors.
What percentage of Crinetics Pharma (CRNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.71% of Crinetics Pharma (CRNX) stock is held by retail investors.
Who owns the most shares of Crinetics Pharma (CRNX)?
Vanguard owns the most shares of Crinetics Pharma (CRNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.